Abstract
Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been shown to increase coronary artery disease (CAD) risk but the data on systemic sclerosis (SSc) is unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing CAD risk in patients with SSc versus non-SSc participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random effect, generic inverse variance method. Four studies were identified and included in our data analysis. The pooled risk ratio of CAD in patients with SSc was 1.82 (95 % CI, 1.40 to 2.36). The statistical heterogeneity of this meta-analysis was moderate with an I 2 of 73 %. Our study demonstrated a statistically significant increased CAD risk among patients with SSc.
Similar content being viewed by others
Reference
Frostegard J (2005) Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 25:1776–1785
Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874
Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48:11–22
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabreil SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732
Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 43:924–929
Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. doi:10.1016/j.semarthrit.2014.03.004
Derk CT, Jimenez SA (2007) Acute myocardial infarction in systemic sclerosis patients: a case series. Clin Rheumatol 26:965–968
Nair CK, Goli-Bijanki R, Lyckholm L, Sketch MH (1988) Inferior myocardial infarction complicated by mural thrombus and systemic embolization despite anticoagulation in progressive systemic sclerosis with normal coronary arteriograms. Am Heart J 116:1357–1359
Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR et al (2008) A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 59:591–597
Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA (2010) Subclinical atherosclerosis in scleroderma patients. Scan J Rheumatol 39:326–329
Heron E, Hernigou A, Chatellier G, Fornes P, Emmerich J, Fiessinger JN (1999) Intracerebral calcification in systemic sclerosis. Stroke 30:2183–2185
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Chu SY, Chen YJ, Liu CJ, Tseng WC, Lin MW, Hwang CY et al (2013) Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 126:982–988
Man A, Zhu Y, Zhang Y, Dubreuil M, Rho YH, Peloquin C et al (2013) The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72:1188–1193
Zoller B, Li X, Sundquist J, Sunquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7:e33442
Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Doornum SV (2012) Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 71:1980–1983
Hettema ME, Bootsma H, Kallenberg CGM (2008) Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 47:578–583
Nussinovitch U, Shoenfeld Y (2011) Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality. Autoimmun Rev 10:259–266
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
Xu J, Lupu F, Esmon CT (2010) Inflammation, innate immunity and blood coagulation. Hamostaseologie 30(5–6):8–9
Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417–430
Conflict of interest
We do not have any financial or nonfinancial potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Database: Ovid MEDLINE
-
1.
exp Scleroderma, Limited/
-
2.
exp Scleroderma, Diffuse/
-
3.
exp Scleroderma, Systemic/
-
4.
exp Scleroderma, Localized/
-
5.
Scleroderma.mp.
-
6.
systemic sclerosis.mp.
-
7.
or/1-6
-
8.
exp Coronary Disease/
-
9.
coronary disease$.mp.
-
10.
exp Coronary Artery Disease/
-
11.
coronary arter$ disease$.mp.
-
12.
exp Coronary Stenosis/
-
13.
coronary stenos$.mp.
-
14.
coronary atheroscleros$.mp.
-
15.
coronary arterioscleros$.mp.
-
16.
(coronary adj3 disease$).mp.
-
17.
(coronary adj3 syndrome$).mp.
-
18.
cad.mp.
-
19.
exp Myocardial Infarction/
-
20.
myocardial infarct$.mp.
-
21.
exp Coronary Thrombosis/
-
22.
coronary thrombos$.mp.
-
23.
exp Angina, Unstable/
-
24.
unstable angina.mp
-
25.
(unstable adj3 angina).mp.
-
26.
exp Angina, Stable/
-
27.
stable angina.mp.
-
28.
exp Angina Pectoris/
-
29.
angina pectoris.mp.
-
30.
acs.mp.
-
31.
ami.mp.
-
32.
or/8-31
-
33.
7 and 32
Rights and permissions
About this article
Cite this article
Ungprasert, P., Charoenpong, P., Ratanasrimetha, P. et al. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 33, 1099–1104 (2014). https://doi.org/10.1007/s10067-014-2681-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2681-4